Stock Price Quote

VELVETTE INTERNATIONAL PHARMA PRODUCTS LTD.

NSE : NABSE : 524528ISIN CODE : INE042F01013Industry : Household & Personal ProductsHouse : Private
BSE3.100 (0 %)
PREV CLOSE ( ) 3.10
OPEN PRICE ( ) 3.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )3.00 3.10
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985
Management Info
- Chairman - Managing Director
Registered Office

Address 23, Dr Ambedkar Road, Kodambakkam,
Chennai,
Tamil Nadu-600024

Phone 044- 30903986 24840264

Email sujathackr@hotmail.com

Website NA

Registrars Details
Trident Investment & Portfolio Services (P) Ltd
Foruth Main road , United India Colony,Kodambakkam,,Chennai
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Sep 04 ANNUAL 04
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Colgate Palmol. (I) (BSE)
peergroup  2855.25 (2.16%)
M.Cap ( in Cr)77658.70
Gillette India (BSE)
peergroup  6256.15 (0.84%)
M.Cap ( in Cr)20385.80
AARTISURF (BSE)
peergroup  657.05 (3.96%)
M.Cap ( in Cr)556.97
Inflame Appliances (BSE)
peergroup  499.20 (4.87%)
M.Cap ( in Cr)366.46
Emami (BSE)
peergroup  480.10 (3.55%)
M.Cap ( in Cr)20956.37

Shareholding Pattern

NON-INSTITUTION 64.4%
PROMOTERS 32.17%
FI/BANKS/INSURANCE 3.36%
MUTUAL FUNDS/UTI 0.07%
GOVERNMENT 0%
FII 0%

About Velvette International Pharma Products Ltd.

Velvette International Pharma Products Ltd. was incorporated in the year 1985. Its today's share price is 3.1. Its current market capitalisation stands at Rs 1.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 9.21 Cr and Total Income of Rs.9.88 Cr. The company's management includes .

It is listed on the BSE with a BSE Code of 524528 , NSE with an NSE Symbol of and ISIN of INE042F01013. It's Registered office is at 23, Dr Ambedkar Road, KodambakkamChennai-600024, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.